Tagrisso cost , (osimertinib) is a kinase inhibitor indicated for the treatment of patients with a specific type of lung cancer (metastatic epidermal growth factor receptor (EGFR) T790M mutation positive non-small cell lung cancer (NSCLC)):
as first-line treatment of patients whose tumours have EGFR exon 19 deletions or exon 21 L858R mutations.
as second line treatment of patients whose disease has progressed on or after EGFR TKI therapy1.
How does Tagrisso (osimertinib) work?
The activity of the epidermal growth factor receptor (EGFR) normally controls growth and division of cells. In lung cancer cells, the EGFR is often overactive, causing uncontrolled division of cancer cells.
By blocking the EGFR, osimertinib helps to reduce the growth and spread of the cancer. Unlike most other tyrosine kinase inhibitors, Tagrisso (osimertinib) is active against cancer cells with the T790M mutation in the EGFR gene. Buy Tagrisso Online at very affordable prices from Cancercureonlinestore.com
Where has Tagrisso (osimertinib) been approved?
Tagrisso (osimertinib) has been approved for advanced or metastatic NSCLC in patients with epidermal growth factor receptor (EGFR) T790M mutation by the following regulatory agencies in the following regions:
- Food and Drug Administration (FDA), USA:
- November 13, 2015, with accelerated approval (second-line treatment)
- March 30, 2017, with regular approval (second-line treatment)
- April 18, 2018, as a first line treatment
- European Medical Agency (EMA), European Union:
- February 2, 2016 (second-line treatment)
- June 11, 2018 (first-line treatment)
- Therapeutic Goods Administration (TGA), Australia, August 3, 2016 (second line treatment)3
If you have a question about its approval in a specific country feel free to contact our support team.
How is Tagrisso (osimertinib) taken?
The standard dosage is:
- 80 mg orally once daily
Note: Please consult with your treating doctor for personalized dosing.
Common adverse reactions
The most common adverse reactions listed in the prescribing information include:
- dry skin
- nail toxicity
The serious adverse reactions listed in the prescribing information include1:
- interstitial lung disease (ILD)/pneumonitis
- heart rate disturbances (QTc Interval Prolongation)
- keratitis (inflammation of the cornea of the eye).
Use in a specific population
Tagrisso (osimertinib) can be fatal for a fetus, it is advised to avoid pregnancies during treatment and for 6 weeks after the final dose. Read more
For a comprehensive list of side effects and adverse reactions please refer to the official prescribing information
Helpful Links: Buy Opdivo Online, Buy Tagrisso Online, Buy Keytruda Online, Buy Imbruvica Online, Buy Tasinga Online, Buy Ibrance Online, Buy Cancer Drugs Online, Anti Cancer drugs, Cancer Treatment in Europe, Cancer Treatments 2018, Cancer Treatment and Side effects, Cancer Treatment in Asia, Buy Opdivo nivolumab online, Buy Tagrisso osimertinib online, Buy Keytruda pembrolizumab online, Buy Imbruvica ibrutinib online, Buy Tasinga nilotinib online, Buy Ibrance palbociclib online